Health minister Mark Butler said reimbursed access to PAXLOVID will include the around 160,000 people between 60-69 years of age with mild to moderate COVID-19 with one additional risk factor for developing severe disease. …
Government further expands access to Pfizer's COVID-19 antiviral
March 30, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
ACT unveils plan to repair New Zealand’s medicines gap by 2033
July 26, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5, Ep.25
July 24, 2026 - - Podcast -
Finalists named for the 2026 Patient's Choice awards
July 24, 2026 - - Latest News -
The 'end of days' language is just a farcical attempt to shut down discussion
July 24, 2026 - - Latest News -
Australian company moving headquarters to US and restructuring workforce
July 24, 2026 - - Latest News -
Faster processes could push Pharmac's options for investment backlog to 400 within two years
July 23, 2026 - - Latest News -
Bellberry and ASCEPT release checklist for 'new approach methodologies' trials
July 23, 2026 - - Latest News